Exam 4 Week 2 Flashcards
Cortisol physiology
10% free in blood, 90% bound (CBG, albumin)
Receptor is cytosolic (HSP-90)
Delayed onset, longer response
Metabolic effects of cortisol
Counter-regulatory hormone:
- Liver gluconeogenesis
- Fatty acid oxidation (centripedal obesity)
- Protein breakdown (increased AA)
- Permissive epi: increased glycogenolysis and HSL activity)
Circulatory effects of cortisol
- Increased RBC production (polycythemia, anemia)
2. Permissive epi: enhance ß-adrenergic activity (CV tone)
Bone effects of cortisol
- Increased cortisol: decreased fibroblast proliferation (decreased collagen synthesis)= thin skin, striae
- Cortisol = vit D antagonist
Anti-inflammatory and immunosuppression effects of cortisol
Inhibits phospholipase A2 (PLC?) to prohibit arachidonic acid formation (affects COX and LOX downstream)
Decreased T cell activation and proliferation (decreased IL-2)
Decreases WBC, but increases neutrophils
Inhibits release of histamine
ACTH derived from
POMC gene
Also includes MSH genes (including on ACTH)
Hypocortisolemia and labs
1˚: Addison’s (destruction)
Cort down, ACTH up, aldo down
2˚: Pituitary or hypothalamus
Cort down, ACTH down, nml aldo (RAAS)
Stress response overview
Two physiologic areas:
- Locus ceruleus: increased NE, arousal
- Hypothalamus: CRH, ACTH, cortisol
- Hypothalamus: Splanchnic nerve, epi
Effects of epi
Increase of blood glucose Increase FFA (via HSL) Decreased insulin (alpha-2 stimulation)
Layers of adrenal gland and production
Glomerulosa: mineralcorticoids (salt)
Fasciculata: glucocorticoids (sugar)
Reticularis: weak androgens, DHEA/androstenedione (sex)
Medulla: epi (and some NE)
Adrenal medulla origin and cell type
Neural crest origin
Chromaffin cells secrete epi and NE
Dopamine/NE pathway
Transporter in/out of vesicle
Enzymes
Tyrosine - L DOPA - Dopamine - NE - Epi
VMAT-1
Tyrosine hydroxylase, Decarboxylase, Dopamine ß-hydroxylase, PNMT
Aldosterone release, effects
Stimulated by ATII and ACTH
Principal cell: K+ out, Na+ in
alpha intercalated cell: H+ out
Hyperaldosteronism
HTN, hypokalemia, metabolic alkalosis (basic pH)
Primary: often bilateral adrenal hypoplasia (low renin)
Secondary: chronic activation of RAAS (high renin)
Ex: CAD, HF, cirrhosis
Types of congenital adrenal hyperplasia
21-OH deficiency: low cort, low aldo, high sex
11-OH deficiency: low cort, nml aldo, high sex
17-OH deficiency: low cort, low sex, high aldo
Pheochromocytoma triad presentation
Intermittent:
Headache
Palpitations
Diaphoresis
Pheo: origin and associated syndromes
Adults Adrenal medulla Chromaffin cells (from neural crest) NF-1, VHL, MEN1/2 (RET) SDHB and SDHD (B=bad, D=dad)
Rule of 10’s for pheo
Malignant Bilateral Extra-adrenal (bladder) Calcify Kids
Pheo dx, imaging, and tx
Urine/plasma metanephrines/catecholamines
Clonidine suppression tet
CT, MRI, I-123 (localize)
Surgical resection after irreversible a-blockers and ß-blockers (phenoxybenzamine)
Genetics follow up!
Paraganglioma
Neuroendocrine derived tumor
Chromaffin negative
Sympathetic
MEN gene associations
MEN2A: Pheo, thyroid carcinoma, hyperparathyroidism
MEN2B: Pheo, thyroid carcinoma, mucosal neuro tumor
2B - often marfanoid habitus
DDx for pheo
Exogenous drug
Hyperthyroidism
Carcinoid tumor
GAD with HTN
Primary hyperaldosteronism (Conn’s)
High aldo, low renin
1/3= adenoma
2/3= bilateral adrenal hypertrophy
rare= carcinoid tumor
Mechanism of glucocorticoid-remediable aldosteronism and treatment
Autosomal dominant
Crossing over between genes for 11-OH and aldose synthase leading to ACTH activated (and overactivated) aldose synthase
= Hyperaldosteronism
Tx: GC’s to suppress ACTH